Experience

Denny Won

    • Sana Biotechnology - $676 million IPO 


    • Wish - $1.1 billion IPO 


    • 4D Molecular Therapeutics - $222 million IPO 


    • AbCellera Biologics - $556 million IPO 


    • Kinnate Biopharma - $276 million IPO 


    • Olema - $240 million IPO 


    • Crinetics Pharmaceuticals – $117 Million IPO 


    • Eidos Therapeutics – $122 Million IPO 


    • Neon Therapeutics – $100 Million IPO 


    • Tricida – $256 Million IPO 


    • Aridis – $26 Million IPO 


    • Gritstone Oncology – $100 Million IPO 


    • Advaxis – $30 Million Registered Direct Offering 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • Sutro Biopharma – $85 Million IPO 


    • Guardant Health – $273.1 Million IPO 


    • Gossamer Bio – $317 Million IPO 


    • ShockWave Medical – $111 Million IPO 


    • Livongo Health - $409 Million IPO 


    • Medallia - $374 Million IPO 


    • Health Catalyst - $209 Million IPO 


    • Akero Therapeutics - $106 Million IPO 


    • 10X Genomics – $449 Million IPO  


    • Exagen Diagnostics – $58 Million IPO  


    • Pliant Therapeutics - $166 Million IPO 


    • The Underwriters On Guardant Health's $1.1 Billion Follow-On Offering 


    • The Underwriters On Livongo Health's $550 Million Convertible Senior Notes 


    • Legend Biotech - $487 Million IPO 


    • Applied Molecular Transport - $177 Million IPO 


    • Acutus Medical – $183 Million IPO 


    • ALX Oncology – $186 Million IPO 


    • Athira Pharma – $204 Million IPO 


    • Inhibrx – $137 Million IPO 


    • Annexon – $251 Million IPO 


    • Arcutis – $192.5 Million Follow-On Offering